Extranodal malignant lymphoma: Detection with FDG PET versus CT

Radiology

Volumn 206, Issue 2, 1998, Pages 475-481

  Moog, Florian ^a   Bangerter, Markus ^a   Diederichs, Christoph G ^a   Guhlmann, Albrecht ^a   Merkte, Elmar ^a   Frickhofen, Norbert ^a   Reske, Sven N ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Computed tomography (CT), comparative studies; Emission CT (ECT), comparative studies; Hodgkin disease; Lymphoma, CT; Lymphoma, radionuclide studies; Non Hodgkin lymphoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; TISSUE DISTRIBUTION;

EID: 0031940343     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.206.2.9457202     Document Type: Article

References (46)

1. Castellino RA, Blank N, Hoppe RT, et al. Hodgkin's disease: contribution of chest CT in the initial staging evaluation. Radiology 1986; 160:603-605.
2. Neumann CH, Robert NJ, Canellos G, et al. Computed tomography of the abdomen and pelvis in non-Hodgkin lymphoma. J Comput Assist Tomogr 1983; 7:846-850.
3. Pond GD, Castellino RA, Horning S, et al. Non-Hodgkin lymphoma: influence of lymphographv, CT, and bone marrow biopsy on staging and management. Radiology 1989; 170:159-164.
4. Pendlebury SC, Koutts J, Boyages J. Hodgkin's disease: clinical and radiological prognostic factors in a laparotomy series. Austral Radiol 1994; 38:123-126.
5. Mauch P, Larson D, Osteen R, et al. Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J Clin Oncol 1990; 8:257-265.
6. Munker R, Stengel A, Stäbler A, et al. Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Cancer 1995; 76:1460-1466.
7. Leibenhaut MH, Hoppe RT, Efron B, et al. Prognostic indicators of laparotomy findings in clinical stage III supradiaphragmatic Hodgkin's disease. J Clin Oncol 1989; 7: 81-91.
8. Som P, Atkins HL, Bandophadhyah D. a fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18). J Nucl Med 1980; 21:670-675.
9. Warburg O. On the origin of cancer cells. Science 1956; 123:309-314.
10. Paul R. Comparison of F-18-2-FDG and gallium-67 citrate: imaging for detection of lymphoma. J Nucl Med 1987; 28:288-292.
11. Hoekstra O, Ossenkoppele GJ, Golding R, et al. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. J Nucl Med 1993; 34:1706-1710.
12. Okada J, Yoshikawa K, Imazeki K, et al. Position emission tomography using fluorine-18-fluorodeoxy-glucose in malignant lymphoma: a comparison with proliferative activity. J Nucl Med 1992; 33:325-329.
13. Lapela M, Leskinen S, Minn H, et al. Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 1995; 9:3522-3527.
14. Leskinen-Kallio S, Ruotsalainen U, Ngren K, et al. Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. J Nucl Med 1991; 32: 1211-1218.
15. Rodriguez M, Rehn S, Ahlström H, et al. Predicting malignancy grade with PET in non-Hodgkin's lymphoma. J Nucl Med 1995; 36:1790-1796.
16. Okada J, Yoshikawa K, Imazeki K, et al. The use of FDG PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. J Nucl Med 1991; 32:686-691.
17. Newman JS, Francis IR, Kaminski MS, et al. Imaging of lymphoma with PET with 2-(F-18)-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 1994; 190:111-116.
18. Moog F, Bangerter M, Diederichs CG, et al. Role of whole body FDG PET in nodal staging of lymphoma. Radiology 1997; 203:795-800.
19. Hoh CK, Glaspy J, Rosen P, et al. Whole-body FDG PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 1997; 38:343-348.
20. Stansfeld AG. Updated Kiel classification for lymphomas. Lancet 1988; 6:292-293.
21. Schmidlin P. Improved iterative image reconstruction using variable projection binning and abbreviated convolution. Eur J Nucl Med 1994; 21:930-936.
22. Castellino RA, Hoppe RT, Blank N, et al. Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin's disease. AJR 1984; 143: 37-41.
23. Zornoza J, Ginaldi S. Computed tomography in hepatic lymphoma. Radiology 1981; 138: 405-410.
24. Kaplan HS, Anderson KC, Leonhard RC: Staging laparotomy and splenectomy in Hodgkin's disease: analysis of indications and patterns of involvement in 285 consecutive, unselected patients. Natl Cancer Inst Monogr 1973; 36:291-298.
25. Rosenberg SA, Berard CW, Brown BW, et al. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical use. Cancer 1982; 49:2112-2135.
26. Fishman EK, Kuhlman JE, Jones RJ. CT of lymphoma: spectrum of disease. RadioGraphics 1991; 11:647-669.
27. Castellino RA. Diagnostic imaging studies in patients with newly diagnosed Hodgkin's disease. Ann Oncol 1992; 3(suppl 4):45-47.
28. Mansfield CM, Fabian C, Jones S, et al. Comparison of lymphangiography and computed tomography scanning in evaluating abdominal disease in stages III and IV Hodgkin's disease. Cancer 1990; 66:2295-2299.
29. Shirkhoda A, Ros PR, Farah J, et al. Lymphoma of the solid abdominal viscera. Radiol Clin North Am 1990; 28:785-799.
30. Skovsgaard T, Brinckmeyer M, Vesterager L, et al. The liver in Hodgkin's disease: II. Histopathologic findings. Eur I Cancer Clin Oncol 1982; 18:429-435.
31. Castellino RA. Imaging techniques for staging abdominal Hodgkin's disease. Cancer Treat Rep 1982; 66:697-700.
32. Ahmann DL, Kiely JM, Harrison EG, et al. Malignant lymphoma of the spleen: a review of 49 cases in which the diagnosis was made at splenectomy. Cancer 1966; 19:461-469.
33. Front D, Bar-Shalom R, Epelbaum R, et al. Early detection of lymphoma recurrence with gallium-67 scintigraphy. J Nucl Med 1993; 34:2101-2104.
34. Front D, Israel O, Epelbaum R, et al. Ga-67 SPECT before and after treatment of lymphoma. Radiology 1990; 175:515-519.
35. Larcos G, Farlow DC, Antico VF, et al. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma. Aust N Z J Med 1994; 24:5-8.
36. Anderson KC, Leonhard RCG, Canellos GP. High-dose gallium imaging in lymphoma. Am J Med 1983; 75:327-334.
37. Hahn PF, Weissleder , Stark DD, et al. MR imaging of focal splenic tumors. AJR 1988; 150:823-827.
38. Weissleder R, Elizondo G, Stark DD, et al. The diagnosis of splenic lymphoma by MR imaging: value of supraparamagnetic iron oxide. AJR 1989; 152:175-180.
39. Tucker MA, Coleman CN, Cox RS: Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318:76-81.
40. Bagley CM, Roth JA, Thomas LB, et al. The liver biopsy in Hodgkin's disease: clinicopathologic correlation in 127 patients. Ann hit Med 1972; 76:219-225.
41. Hoane BR, Shields AF, Porter BA, et al. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood 1991; 78:728-738.
42. Tesoro-Tess JD, Balzarini L, Ceglia E, Petrillo R, Santoro A, Musumeci R. Magnetic resonance imaging in the initial staging of Hodgkin's disease and non-Hodgkin lymphoma. Eur J Radiol 1991; 12:81-90.
43. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorode-oxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
44. Jones HA, Clark RJ, Rhodes CG, et al. In vivo measurements of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med 1994; 149:1635-1639.
45. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med 1995; 36:1836-1839.
46. Hoffman JM, Waskin HA, Hanson MW, et al. FDG PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993; 34:567-575.